Abstract Objectives: Despite promising advances in metabolomics for biomarker discovery in systemic lupus erythematosus (SLE), studies examining associations with detailed disease phenotypes, including organ damage and validated outcome measures, remain limited. We aimed to explore associations between serum metabolomic profiles with SLE phenotypes. Methods: Untargeted serum metabolomics was performed in 60 SLE patients using liquid chromatography-mass spectrometry.